Dry eye treatment is tailored to the cause of tear-film dysfunction and the condition of the eyelids. Examination guides a care plan whose effect is reviewed at follow-up visits.
Patients with burning, grittiness, dryness or episodic tearing, especially symptoms that worsen in the evening, during reading or screen work. Patients after refractive or other ophthalmic surgery when ocular-surface dryness persists or interferes with recovery.
People with fluctuating or blurry vision that temporarily clears after blinking when no other obvious cause explains the symptom.
Patients with meibomian gland dysfunction, chronic blepharitis, obstructed gland orifices or a strong evaporative component.
Contact-lens users who develop lens intolerance, dryness, redness or shorter comfortable wear time.
Patients with systemic risk factors, including autoimmune disease, diabetes, hormonal change or medicines that can affect tear production.
People who have used lubricating drops for a long time without sustained relief and want the underlying mechanism assessed.
There is no single contraindication list because the service includes several diagnostic and therapeutic options.
Restrictions depend on the selected method and ocular-surface condition.
Punctal occlusion, physiotherapy and other procedures are used only when indicated.
Prescription anti-inflammatory medicines should not be self-started.
Bring a complete list of eye drops and systemic medicines, including allergy, blood-pressure, sleep and mood medicines. Some drugs may worsen dryness, but they should not be stopped without the prescribing clinician.
If you wear contact lenses, report the type, wearing schedule and tolerance. Ask KazRIED in advance whether lenses should be removed before testing and for how long.
Bring previous eye-surface or dry-eye test results if available so the clinician can assess response and progression.
Tell the clinician about dry mouth, joint symptoms, autoimmune disease, thyroid disease, diabetes, menopause and previous eye or eyelid surgery.
Do not start new antibiotics, steroid eye drops or other prescription medicines before the visit without a prescription.
If symptoms worsen suddenly, with severe pain, photophobia, vision loss , trauma or purulent discharge, seek urgent assessment rather than routine dry-eye testing. Active infection, marked inflammation, trauma, chemical injury, corneal ulceration or sudden vision loss require a separate urgent pathway rather than routine dry-eye treatment.
Seek urgent assessment for severe pain, marked photophobia, purulent discharge, sudden vision loss or a painful red eye in a contact-lens wearer.
There is no single contraindication list because the service includes several diagnostic and therapeutic options.
Book a consultation
The clinician reviews symptoms, screen exposure, contact lenses, medication, previous surgery and systemic disease.
The cornea, conjunctiva, lid margin and signs of meibomian gland dysfunction are assessed.
Tear-film stability, tear volume or production and related parameters are measured when indicated.
Management differs when disease is predominantly evaporative, aqueous deficient or mixed.
Options may include environmental changes, lubricants, eyelid therapy, prescription treatment, physiotherapy or selected surgical measures.
Symptoms and objective signs are reassessed, treatment is modified if needed and relevant comorbidities are investigated.
Selected treatment can reduce burning, grittiness and discomfort associated with tear film dysfunction.
Lubrication and inflammation treatment help protect the ocular surface from dryness-related damage.
Treatment is selected for the dryness mechanism to improve lubrication and reduce excessive tear evaporation when present.
Reducing dryness can make screen use more comfortable and reduce fluctuating blur caused by unstable tears.
Book an ophthalmology consultation and ocular-surface assessment at KazRIED to identify the mechanism of dryness and determine an appropriate treatment pathway. If the dedicated dry-eye module is needed, confirm its availability at the selected branch when booking.
A team of experienced doctors across specialties.
Candidate of Medical Sciences; Highest-category ophthalmologist
Highest-category ophthalmologist
Highest-category ophthalmologist
Highest-category ophthalmologist
Highest-category ophthalmologist
Highest-category ophthalmologist
Highest-category ophthalmologist
First-category ophthalmologist
Second-category ophthalmologist
Second-category ophthalmologist
Dry eye disease is a multifactorial disease of the ocular surface involving loss of tear film stability. Increased evaporation, insufficient aqueous tear production, inflammation, epithelial damage, and altered sensitivity may coexist.
Treatment aims to improve tear film quality and stability, protect the cornea and conjunctiva, and reduce burning, grittiness, redness, and fluctuating vision.
Two goals matter: relieving discomfort and addressing the disease mechanism. Lubricating drops may relieve symptoms without fully addressing the cause of ocular surface instability.
KazRIED describes medical, surgical, and physiotherapeutic approaches. The need for each is determined individually after an examination.
The plan may include:
More invasive methods are considered for persistent symptoms, specific disease mechanisms, or complications.
Eyelid massage may be used for meibomian gland dysfunction when prescribed by a clinician.
Laser therapy and magnetic field therapy are listed as general physiotherapy procedures. Their suitability for dry eye disease and the specific treatment course require confirmation by the clinician.
The outcome is assessed through subjective comfort and changes in ocular surface findings over time. Treatment is adjusted when necessary.
Conditions that may feel like “dryness” are also excluded: infectious keratitis, allergic inflammation, corneal injury, eyelid malposition, and neuropathic pain.
If symptoms are substantially greater than the clinical signs or persist after ocular surface recovery, the clinician may broaden the diagnostic assessment.
The consultation, diagnostic module, medications, and individual procedures do not automatically constitute a single treatment course at one price. The treatment components are determined by the clinician’s prescriptions.
Kazakhstan’s first specialized ophthalmology institute, operating since 1933.
Modern diagnostics and surgery using world-class equipment.
Leading ophthalmologists in Kazakhstan, scientists and experienced surgeons.
More than 30,000 operations and around 270,000 consultations annually.
Kazakhstan’s first specialized ophthalmology institute, operating since 1933.
Modern diagnostics and surgery using world-class equipment.
Leading ophthalmologists in Kazakhstan, scientists and experienced surgeons.
More than 30,000 operations and around 270,000 consultations annually.
Kazakhstan’s first specialized ophthalmology institute, operating since 1933.
Modern diagnostics and surgery using world-class equipment.
Leading ophthalmologists in Kazakhstan, scientists and experienced surgeons.
More than 30,000 operations and around 270,000 consultations annually.
